Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice.

Edwards RA, Wang K, Davis JS, Birnbaumer L.

Inflamm Bowel Dis. 2008 Jul;14(7):898-907. doi: 10.1002/ibd.20414.

2.

Id1 Deficiency Protects against Tumor Formation in Apc(Min/+) Mice but Not in a Mouse Model of Colitis-Associated Colon Cancer.

Zhang N, Subbaramaiah K, Yantiss RK, Zhou XK, Chin Y, Benezra R, Dannenberg AJ.

Cancer Prev Res (Phila). 2015 Apr;8(4):303-11. doi: 10.1158/1940-6207.CAPR-14-0411. Epub 2015 Jan 26.

3.

MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.

Chen Y, Du J, Zhang Z, Liu T, Shi Y, Ge X, Li YC.

Inflamm Bowel Dis. 2014 Nov;20(11):1910-8. doi: 10.1097/MIB.0000000000000158.

4.

A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, Augenlicht L, Lin EY.

Am J Pathol. 2010 Feb;176(2):952-67. doi: 10.2353/ajpath.2010.090622. Epub 2009 Dec 30.

6.

Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.

Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS.

Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.

7.

Gi2 alpha protein deficiency: a model of inflammatory bowel disease.

Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, Birnbaumer L.

J Clin Immunol. 1995 Nov;15(6 Suppl):101S-105S.

PMID:
8613481
8.

Interplay between T(h)1 and T(h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the Gαi2-deficient mouse.

Götlind YY, Fritsch Fredin M, Kumawat AK, Strid H, Willén R, Rangel I, Bland PW, Hörnquist EH.

Int Immunol. 2013 Jan;25(1):35-44. doi: 10.1093/intimm/dxs089. Epub 2012 Sep 7.

PMID:
22962436
9.

The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.

Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A, Mantovani A, Locati M, Danese S.

Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20.

PMID:
19846409
10.

Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.

Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C.

Pharmacol Res. 2012 Jul;66(1):66-79. doi: 10.1016/j.phrs.2012.03.013. Epub 2012 Mar 28.

PMID:
22475725
11.

Lessons from genetic models of inflammatory bowel disease.

Podolsky DK.

Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5. Review.

PMID:
9260328
12.

Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.

Dai Y, Jiao H, Teng G, Wang W, Zhang R, Wang Y, Hebbard L, George J, Qiao L.

Mol Cancer Ther. 2014 May;13(5):1206-16. doi: 10.1158/1535-7163.MCT-13-0378. Epub 2014 Mar 20.

14.

Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice.

Craven B, Zaric V, Martin A, Mureau C, Egan LJ.

Inflamm Bowel Dis. 2015 Mar;21(3):485-95. doi: 10.1097/MIB.0000000000000303.

PMID:
25581824
15.

Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.

Tang R, Yang G, Zhang S, Wu C, Chen M.

Inflamm Bowel Dis. 2014 Nov;20(11):1950-61. doi: 10.1097/MIB.0000000000000192.

PMID:
25208103
16.

Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice.

Bjursten M, Bland PW, Willén R, Hörnquist EH.

Eur J Immunol. 2005 Aug;35(8):2274-83.

17.

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.

Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, de Jong YP, Ooi CJ, Xavier RJ, Terhorst C, Podolsky DK, Bhan AK.

Gastroenterology. 2002 Jan;122(1):134-44.

PMID:
11781288
18.

Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.

Sakurai T, Kashida H, Watanabe T, Hagiwara S, Mizushima T, Iijima H, Nishida N, Higashitsuji H, Fujita J, Kudo M.

Cancer Res. 2014 Nov 1;74(21):6119-28. doi: 10.1158/0008-5472.CAN-14-0471. Epub 2014 Sep 3.

19.

Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.

Svec J, Ergang P, Mandys V, Kment M, Pácha J.

Int J Exp Pathol. 2010 Feb;91(1):44-53. doi: 10.1111/j.1365-2613.2009.00698.x.

20.

Chronic inflammatory bowel disease and cancer.

Pohl C, Hombach A, Kruis W.

Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Review.

PMID:
10690586

Supplemental Content

Support Center